Chen-han Chueh

Title(s)Postdoctoral Scholar, Herbert Wertheim School of Public Health & Human Longevity Science
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma. Cost Eff Resour Alloc. 2026 Feb 10; 24(1). Wang IT, Chen HL, Huang WM, Chiang NJ, Shen LJ, Chueh CH, Tsai YW. PMID: 41668195; PMCID: PMC12990505.
      View in: PubMed   Mentions:
    2. Cost-effectiveness of lenvatinib plus pembrolizumab as the second-line treatment for advanced endometrial carcinoma. Cost Eff Resour Alloc. 2026 Jan 14; 24(1). Chiang ST, Chueh CH, Wen YW, Chiang SC, Li WH, Tsai YW. PMID: 41535916; PMCID: PMC12969905.
      View in: PubMed   Mentions:
    3. Modeling brain metastases in cost effectiveness analysis of atezolizumab for extensive stage small cell lung cancer. Sci Rep. 2025 Nov 10; 15(1):39298. Chen HL, Chueh CH, Huang WM, Chan SH, Cheng HH, Chiang SC, Wu CE, Wen YW, Tsai YW. PMID: 41214083; PMCID: PMC12603174.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan. Br J Clin Pharmacol. 2025 Oct 26. Huang WM, Chueh CH, Tseng CY, Kaufmann CN, Morris EJ, Wu CE, Tsai YW. PMID: 41140009.
      View in: PubMed   Mentions:    Fields:    
    5. The Cost-Effectiveness of Sugemalimab Plus CAPOX in Treating Advanced Gastric Cancer: Analysis from the GEMSTONE-303 Trial. Cancers (Basel). 2025 Sep 29; 17(19). Chueh CH, Huang WM, Hong MY, Tsai YW, Chiang NJ, Chen HL. PMID: 41097699; PMCID: PMC12523858.
      View in: PubMed   Mentions: 2  
    6. Association between prehospital medical service complexity and perceived task load of emergency calls among paramedics in Taiwan: a nationwide survey study. Sci Rep. 2025 May 25; 15(1):18201. He YW, Chueh CH, Yu HJ, Huang CY, Meng YH, Lin CH, Tsai YW, Kales SN, Lan FY. PMID: 40414960; PMCID: PMC12104446.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Impact of same-day ART initiation on medical care and medication discontinuation among patients with incident HIV infection or AIDS in Taiwan: A population-based cohort study. J Infect Public Health. 2025 Apr; 18(4):102677. Chueh CH, Yu HJ, Wen YW, Shiu MN, Chen YY, Chiang SC, Tsai YW. PMID: 39893713.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    8. Pharmaceutical procurement profits and universal health coverage: Reform to a sustainable healthcare and financing system. J Formos Med Assoc. 2024 Nov; 123 Suppl 3:S242-S250. Huang WF, Fu JK, Chueh CH, Chen HH, Shen LJ, Tsai YW. PMID: 39379262.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. The 2017 Women's Health Initiative study and use of hormone therapy: an emulated repeated cross-sectional study. BMC Public Health. 2024 06 24; 24(1):1674. Chueh CH, Ho PK, Li WH, Shiu MN, Wang IT, Wen YW, Tsai YW. PMID: 38914983; PMCID: PMC11194959.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    10. Cost-effectiveness of ivosidenib versus chemotherapy for previously treated IDH1-mutant advanced intrahepatic cholangiocarcinoma in Taiwan. BMC Cancer. 2024 May 22; 24(1):622. Chen KA, Huang WM, Chen EY, Ho PK, Chueh CH, Wen YW, Chen MH, Chiang NJ, Tsai YW. PMID: 38778261; PMCID: PMC11110281.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Cost-effectiveness of pemigatinib as a second-line treatment for advanced intrahepatic cholangiocarcinoma with fibroblast growth factor receptor 2 fusions in Taiwan: from the evidence of the phase II trial and the perspective of Taiwan's National Health Insurance Administration. Cost Eff Resour Alloc. 2023 Sep 11; 21(1):61. Chen ZR, Chueh CH, Chiang NJ, Tsai YW. PMID: 37697368; PMCID: PMC10496386.
      View in: PubMed   Mentions: 7  
    12. Cost-Effectiveness Analysis of a New Second-Line Treatment Regimen for Advanced Intrahepatic Cholangiocarcinoma: Biomarker-Driven Targeted Therapy of Pemigatinib Versus 5-FU Chemotherapy. Pharmacoeconomics. 2023 03; 41(3):307-319. Chueh CH, Tsai YW, Chen ZR, Shiu MN, Wen YW, Chiang NJ. PMID: 36575331.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    13. Impacts of intervals between sequential development of depression and dementia in older adults: A nationwide population-based study. Arch Gerontol Geriatr. 2022 Jul-Aug; 101:104693. Yang SN, Chueh CH, Peng LN, Tsai YW. PMID: 35390572.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    Chen-han's Networks
    Concepts (53)
    Derived automatically from this person's publications.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California